Locke CS - Search Results

1

Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration.

Carr RA, Edmonds A, Shi H, Locke CS, Gustavson LE, Craft JC, Harris SI, Palmer R. Carr RA, et al. Among authors: locke cs. Antimicrob Agents Chemother. 1998 May;42(5):1176-80. doi: 10.1128/AAC.42.5.1176. Antimicrob Agents Chemother. 1998. PMID: 9593146 Free PMC article. Clinical Trial.

2

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state.

Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schneck DW. Gustavson LE, et al. Among authors: locke cs. Antimicrob Agents Chemother. 1995 Sep;39(9):2078-83. doi: 10.1128/AAC.39.9.2078. Antimicrob Agents Chemother. 1995. PMID: 8540719 Free PMC article. Clinical Trial.

3

Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.

Samara EE, Gustavson LE, El-Shourbagy T, Locke C, Granneman GR, Sommerville KW. Samara EE, et al. Epilepsia. 1998 Aug;39(8):868-73. doi: 10.1111/j.1528-1157.1998.tb01182.x. Epilepsia. 1998. PMID: 9701378 Clinical Trial.

4

The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar).

Carr RA, André AK, Chen P, Grabowski BA, Chang MS, Locke CS, Williams LA, Chojkier M. Carr RA, et al. Among authors: locke cs. Nephron Clin Pract. 2006;103(3):c100-5. doi: 10.1159/000092018. Epub 2006 Mar 13. Nephron Clin Pract. 2006. PMID: 16534233

5

Dual effects of rifampin on the pharmacokinetics of atrasentan.

Xiong H, Carr RA, Locke CS, Katz DA, Achari R, Doan TT, Wang P, Jankowski JR, Sleep DJ. Xiong H, et al. Among authors: locke cs. J Clin Pharmacol. 2007 Apr;47(4):423-9. doi: 10.1177/0091270007299928. J Clin Pharmacol. 2007. PMID: 17389551 Clinical Trial.

6

Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects.

Hsu A, Granneman GR, Witt G, Locke C, Denissen J, Molla A, Valdes J, Smith J, Erdman K, Lyons N, Niu P, Decourt JP, Fourtillan JB, Girault J, Leonard JM. Hsu A, et al. Antimicrob Agents Chemother. 1997 May;41(5):898-905. doi: 10.1128/AAC.41.5.898. Antimicrob Agents Chemother. 1997. PMID: 9145841 Free PMC article. Clinical Trial.

7

The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.

Awni WM, Braeckman RA, Locke CS, Dubé LM, Granneman GR. Awni WM, et al. Among authors: locke cs. Clin Pharmacokinet. 1995;29 Suppl 2:98-104. doi: 10.2165/00003088-199500292-00014. Clin Pharmacokinet. 1995. PMID: 8620678 Clinical Trial.

8

Effect of zileuton on theophylline pharmacokinetics.

Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dubé LM, Awni WM. Granneman GR, et al. Among authors: locke cs. Clin Pharmacokinet. 1995;29 Suppl 2:77-83. doi: 10.2165/00003088-199500292-00011. Clin Pharmacokinet. 1995. PMID: 8620674 Clinical Trial.

9

Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma.

Samara E, Cao G, Locke C, Granneman GR, Dean R, Killian A. Samara E, et al. Clin Pharmacol Ther. 1997 Oct;62(4):426-35. doi: 10.1016/S0009-9236(97)90121-1. Clin Pharmacol Ther. 1997. PMID: 9357394 Clinical Trial.

10

Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin.

Karol MD, Locke CS, Cavanaugh JH. Karol MD, et al. Among authors: locke cs. J Clin Pharmacol. 1999 Dec;39(12):1283-9. doi: 10.1177/00912709922011971. J Clin Pharmacol. 1999. PMID: 10586395 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters